Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 389.00
+11.50 (3.05%)
Sep 11, 2026, 3:29 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 33.51 billion as of September 11, 2026. Its market cap has increased by 272.71% in one year.
Market Cap
33.51B
Enterprise Value
29.30B
Revenue
6.74B
Ranking
n/a
PE Ratio
59.52
Stock Price
389.00
ChartMarket Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 33.51B, an increase of 29,950.63%. That is a compound annual growth rate of 23.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 33.51B | 365.81% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 74.97B |
| Innova Captab | 65.65B |
| Sun Pharma Advanced Research Company | 63.61B |
| Orchid Pharma | 50.87B |
| RPG Life Sciences | 44.63B |
| Solara Active Pharma Sciences | 36.15B |
| Sakar Healthcare | 25.78B |
| Indoco Remedies | 24.28B |